Core Viewpoint - 惠理集团 reported a strong performance for the six months ending June 30, 2025, with significant profit growth driven by investment returns, despite a decline in total revenue [1] Financial Performance - Total revenue for the period was HKD 221 million, a year-on-year decrease of 6.3% [1] - Profit attributable to owners was HKD 252 million, reflecting a year-on-year increase of 572.7% [1] - Basic earnings per share were HKD 0.138 [1] Investment and Fundraising - The strong performance was primarily attributed to investment returns from proprietary funds, which offset a slight decline in management fees [1] - Total subscriptions for the first half of 2025 reached USD 733 million, indicating continued growth in fundraising [1] - Notably, there was strong inflow into focus funds in mainland China, and high demand for the company's USD money market fund [1] Financial Position - As of June 30, 2025, the group maintained a robust balance sheet with a net asset value of HKD 3.8 billion [1] - This includes cash and cash equivalents of HKD 1.5 billion and investments totaling HKD 2.3 billion [1] - The company continues to uphold prudent financial management to ensure strategic flexibility and resilience for long-term growth [1]

Core Viewpoint - 惠理集团 reported a strong performance for the six months ending June 30, 2025, with significant profit growth driven by investment returns, despite a slight decline in management fees [1] Financial Performance - Total revenue for the period was HKD 221 million, a year-on-year decrease of 6.3% [1] - Profit attributable to shareholders reached HKD 252 million, marking a year-on-year increase of 572.7% [1] - Basic earnings per share were HKD 0.138 [1] Investment and Fundraising - The company maintained a strong fundraising momentum in the first half of 2025, with total subscriptions amounting to USD 733 million [1] - Notably, there was strong inflow into focus funds from mainland China, and high demand for the 惠理美元货币基金 [1] - Increasing investor interest in the company's income-oriented strategies, such as the 惠理亚洲股债收益基金, was observed [1] Balance Sheet and Financial Management - As of June 30, 2025, the group maintained a robust balance sheet with a net asset value of HKD 3.8 billion [1] - This includes cash and cash equivalents of HKD 1.5 billion and investments totaling HKD 2.3 billion [1] - The company continues to uphold prudent financial management to ensure strategic flexibility and resilience for long-term growth [1]

Core Viewpoint - 惠理集团 reported a significant increase in profit despite a decline in total revenue, indicating strong performance in investment activities [1] Financial Performance - Total revenue for the six months ended June 30, 2025, was HKD 221 million, a decrease of 6.3% year-on-year [1] - Profit attributable to owners surged to HKD 252 million, reflecting a substantial increase of 572.7% year-on-year [1] - Basic earnings per share were HKD 0.138 [1] Investment and Fundraising - The strong performance was primarily driven by returns from proprietary investments, which offset a slight decline in management fees [1] - Total subscriptions for the first half of 2025 reached USD 733 million, with notable performance from mainland China-focused funds and the 惠理 USD Money Market Fund [1] - The income-oriented strategy attracted more investors [1] Asset Management - As of June 30, 2025, the group's net asset value stood at HKD 3.8 billion, comprising HKD 1.5 billion in cash and cash equivalents, and HKD 2.3 billion in investments [1]

Core Viewpoint - 惠理集团 reported a total revenue of HKD 221 million for the six months ending June 30, 2025, representing a year-on-year decline of 6.3%, while the profit attributable to shareholders surged to HKD 252 million, a significant increase of 572.7% [1] Financial Performance - Total revenue for the period was HKD 221 million, down 6.3% year-on-year [1] - Profit attributable to shareholders reached HKD 252 million, up 572.7% year-on-year [1] - Basic earnings per share were HKD 0.138 [1] Investment Performance - Strong performance was primarily driven by investment income from proprietary funds, which offset a slight decline in management fees [1] - The total subscription amount for fundraising in the first half of 2025 was USD 733 million [1] - Notably, the mainland China-focused funds experienced strong inflows, and there was significant demand for the 惠理美元货币基金 [1] Asset Management - As of June 30, 2025, the group maintained a robust balance sheet with a net asset value of HKD 3.8 billion [1] - This includes cash and cash equivalents of HKD 1.5 billion and investments totaling HKD 2.3 billion [1] - The group continues to uphold prudent financial management to ensure strategic flexibility and resilience for long-term growth [1]

Core Viewpoint - 惠理集团 reported a total revenue of HKD 221 million for the six months ending June 30, 2025, representing a year-on-year decline of 6.3%, while profit attributable to shareholders surged to HKD 252 million, a significant increase of 572.7% [1] Financial Performance - Total revenue for the period was HKD 221 million, down 6.3% year-on-year [1] - Profit attributable to shareholders reached HKD 252 million, up 572.7% year-on-year [1] - Basic earnings per share were HKD 0.138 [1] Investment Performance - Strong performance was primarily driven by investment income from proprietary funds, which offset a slight decline in management fees [1] - The total subscription amount for fundraising in the first half of 2025 was USD 733 million [1] - Notably, the mainland China-focused funds experienced strong inflows, and there was significant demand for the 惠理美元货币基金 [1] Asset Management - As of June 30, 2025, the group maintained a robust balance sheet with a net asset value of HKD 3.8 billion [1] - This includes cash and cash equivalents of HKD 1.5 billion and investments totaling HKD 2.3 billion [1] - The group continues to adhere to prudent financial management, ensuring strategic flexibility and resilience for long-term growth [1]

格隆汇8月13日丨惠理集团(00806.HK)公布，截至2025年6月底中期，公司收入总额2.21亿港元，同比减 少6.3%。集团录得2.52亿港元净利润，较去年同期的3,700万港元大幅提升。强劲业绩主要得益于自有 资金投资的投资收益，该收益抵销了管理费的轻微下滑。 ...

Financial Performance - Total revenue for the six months ended June 30, 2025, was HKD 220.8 million, a decrease of 6.3% compared to HKD 235.7 million in 2024[2] - Total management fees decreased by 7.6% to HKD 185.6 million from HKD 200.8 million in the previous year[2] - Performance fees dropped significantly by 40.2% to HKD 5.8 million from HKD 9.7 million[2] - The company reported an operating loss of HKD 19.7 million, a decline of 3,383.3% compared to an operating profit of HKD 0.6 million in 2024[2] - Profit attributable to owners of the company surged by 572.7% to HKD 251.6 million from HKD 37.4 million[2] - Basic and diluted earnings per share increased by 590.0% to HKD 13.8 from HKD 2.0[2] - Net income for the period was HKD 251.6 million, compared to HKD 37.4 million in the previous year[4] - Total comprehensive income for the period was HKD 281.0 million, up from HKD 28.4 million in 2024[4] - The financial results indicate a strong recovery in profitability despite a decline in revenue and management fees[3] Assets and Investments - Non-current assets totaled HKD 2,427,321,000 as of June 30, 2025, slightly down from HKD 2,538,300,000 at the end of 2024[5] - Cash and cash equivalents increased to HKD 1,524,960,000 from HKD 1,077,437,000, marking a growth of 41.5%[5] - The total equity attributable to owners increased to HKD 3,814,780,000 from HKD 3,552,063,000, reflecting a growth of 7.4%[5] - As of June 30, 2025, the investment in joint ventures amounted to HKD 555.9 million, an increase from HKD 479.7 million as of December 31, 2024, representing a growth of approximately 15.5%[16] - The total investment amount as of June 30, 2025, was HKD 1,321.5 million, compared to HKD 1,749.1 million as of December 31, 2024, reflecting a decrease of approximately 24.5%[19] - The amount invested in associates was HKD 334 million as of June 30, 2025, down from HKD 568 million as of December 31, 2024, indicating a reduction of approximately 41.3%[20] Dividends and Shareholder Returns - The company did not declare an interim dividend for the period[2] - The company declared a final dividend of HKD 18,267,000 for the year ended December 31, 2024, with no interim dividend proposed for the six months ended June 30, 2025[14] Operational Highlights - The company is actively developing new products to capture emerging opportunities in the market, particularly in AI, blockchain, and virtual assets[29] - The company has strengthened its customer interactions and expanded distribution channels through various cross-border initiatives, enhancing its role as a connector between mainland China and international markets[32] - The company is applying for MRF mutual recognition qualifications for multi-asset and fixed-income strategy products to expand its distribution in the mainland retail market[33] - The company continues to collaborate with domestic institutions to develop customized investment solutions, enhancing its product offerings for both institutional and retail clients[34] Fund Performance - The flagship product, the high-dividend stock fund, attracted significant capital inflows, reflecting investor confidence in the company's income-oriented strategies[33] - The flagship product, the High Yield Equity Fund, achieved a year-to-date return of 14.5%, reaching a historical high, demonstrating the ability to generate sustainable income and capital appreciation through a diversified Asian high-yield equity portfolio[39] - The Asia Income Series Fund recorded a year-to-date return of 10.7%, ranking in the top 25% among similar funds as of June 30, 2025[39] - The China Focus Fund achieved a year-to-date return of 13.9%, reflecting investor confidence in the company's local expertise, with net inflows recorded[40] - The Value Gold ETF delivered an impressive year-to-date return of 26.6%, solidifying its reputation as one of the top products in the region[41] Strategic Initiatives - The company is actively seeking to expand its ETF product lineup, focusing on innovative products related to tokenization and virtual assets, as well as diversified asset classes including gold[43] - The company has successfully invested in several innovative medical enterprises, including a $123 million Series E funding round for a company focused on AI-driven drug development[42] - The company is enhancing its core investment capabilities, optimizing coverage of equities and fixed income in the Asia-Pacific region, and exploring global asset opportunities[44] - The company has established strategic partnerships in Southeast Asia, including Singapore and Malaysia, to capture growth in the region and enhance service diversification[36] - The company is advancing its private equity business, focusing on high-potential areas such as artificial intelligence and biotechnology[37] Corporate Governance - The company established an audit committee consisting of three independent non-executive directors to comply with the listing rules of the Hong Kong Stock Exchange[82] - The interim results for the six months ending June 30, 2025, have been reviewed by the external auditor in accordance with Hong Kong Review Standards[83] - The company is committed to maintaining high standards of corporate governance and has adhered to the corporate governance code as of June 30, 2025[84] - All directors confirmed compliance with the standard code for securities transactions as of June 30, 2025[85] Employee and Cost Management - The group employed 106 staff in Hong Kong as of June 30, 2025, down from 125 a year earlier, and maintained a competitive compensation structure to reward employee contributions[80] - The group continues to adopt a cautious approach to cost management while investing in key strategic growth areas to enhance competitive advantage[72] - The group has implemented resource adjustments and ongoing cost control measures to address future business challenges[72]

Group 1 - Recent data indicates a surge in international capital reallocating towards Chinese assets, with nearly 60% of sovereign wealth funds prioritizing China as an investment market [1][2] - Korean investors have shown increasing enthusiasm for Chinese stocks, with a cumulative trading volume of $5.764 billion in 2023, making China the second-largest overseas investment destination for Korean investors [2] - UBS's survey reveals that 19% of global family offices plan to increase their allocation to Chinese assets, marking a 3 percentage point increase from 2024 [2] Group 2 - In July, five major overseas Chinese stock ETFs attracted over $2 billion in investments, with significant growth in assets under management for several ETFs [3] - Sovereign wealth funds are driven to allocate to Chinese assets due to attractive local returns, diversification benefits, and expanded market access for foreign investors [3] Group 3 - The Chinese economy's recovery has exceeded market expectations, bolstered by rapid policy responses to stabilize expectations and stimulate growth, enhancing international investor confidence [4] - China has made significant advancements in technology and innovation, leading to a re-evaluation of asset valuations by international investors [4] Group 4 - As of August 1, four A-share stocks have over 24% foreign ownership, indicating strong foreign interest in companies with global competitiveness [5] - Foreign investors are selectively investing in growth stocks, focusing on companies with sustainable performance and expanding market shares [6] Group 5 - Foreign capital is favoring high-dividend stocks and growth stocks, reflecting a dual strategy of defense and offense in investment [7] - High-dividend stocks are recognized for their stable cash flows and strong governance, while growth stocks represent long-term bets on China's economic transformation [8]

致：香港交易及結算所有限公司 公司名稱: 惠理集團有限公司 (於開曼群島註冊成立之有限責任公司) 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 FF301 截至月份: 2025年7月31日 狀態: 新提交 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00806 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 1,826,709,831 | | 0 | | 1,826,709,831 | | 增加 / 減少 (-) | | | 0 | | 0 | | | | 本月底結存 | | | 1,826,709,831 | | 0 | | 1,826,709,831 | 第 2 頁 共 10 頁 v 1.1.1 | 1. 股份 ...

Core Viewpoint - The company, 惠理集团 (00806.HK), has scheduled a board meeting on August 13, 2025, to consider and approve its unaudited interim results for the six months ending June 30, 2025, and to discuss the potential declaration of an interim dividend, if applicable [1] Summary by Categories - **Company Performance** - The board meeting will focus on the unaudited interim results for the six months ending June 30, 2025 [1] - **Dividend Consideration** - The meeting will also consider the declaration of an interim dividend, subject to approval [1]